Filing Details
- Accession Number:
- 0001127602-21-006424
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-18 13:05:19
- Reporting Period:
- 2021-02-16
- Accepted Time:
- 2021-02-18 13:05:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242753 | E Mark Tryniski | 1964 Penfold Way Baldwinsville NY 13027 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-16 | 1,000 | $27.63 | 43,889 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 229 | $120.69 | 43,660 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 1,000 | $26.09 | 44,660 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 217 | $120.69 | 44,443 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 1,000 | $32.93 | 45,443 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 273 | $120.69 | 45,170 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 1,000 | $39.64 | 46,170 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 329 | $120.69 | 45,841 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 1,000 | $53.83 | 46,841 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 462 | $120.69 | 46,379 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 7,195 | $41.06 | 53,574 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 2,420 | $122.10 | 51,154 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-02-16 | 2,230 | $120.88 | 48,924 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-16 | 2,545 | $121.31 | 46,379 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2021-02-16 | 1,000 | $0.00 | 1,000 | $27.63 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2021-02-16 | 1,000 | $0.00 | 1,000 | $26.09 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2021-02-16 | 1,000 | $0.00 | 1,000 | $32.93 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2021-02-16 | 1,000 | $0.00 | 1,000 | $39.64 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2021-02-16 | 1,000 | $0.00 | 1,000 | $55.70 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-02-16 | 7,195 | $0.00 | 7,195 | $41.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-06-01 | 2021-06-01 | No | 4 | M | Direct |
| 0 | 2013-06-01 | 2022-06-01 | No | 4 | M | Direct |
| 0 | 2014-06-01 | 2023-06-01 | No | 4 | M | Direct |
| 0 | 2015-06-01 | 2024-09-11 | No | 4 | M | Direct |
| 0 | 2016-06-01 | 2025-06-01 | No | 4 | M | Direct |
| 0 | 2017-06-01 | 2026-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.56 to $121.15. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.21 to $122.11. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.
- The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service.
- The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
Billionaire Hedge Funds
